5 completed, 2 unknown. 5 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 3, Unknown 2 |
| Phase 3 | 1 | Completed 1 |
Follow alcaftadine: new trials by email Literature Review of alcaftadine trials Research Report on alcaftadine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea Alcaftadine Ophthalmic Solution 0.25% - Conjunctivitis, Allergic | Completed | Allergan | 3423 | 2015-10-19 | 2019-07-05 | |
| A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy Lastacaft ®, Tears Naturale ® (Placebo) - Allergic Conjunctivitis | Phase 4 | Completed | ORA, Inc. | 25 | 2014-12-01 | 2021-03-18 |
| Ocular Allergy Treatment Practical Impact Trial Alcaftadine - Allergic Conjunctivitis, Rhinoconjunctivitis | Phase 4 | Unknown | Starx Research Center, LLC | 50 | 2013-04-01 | 2013-05-30 |
| A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis Alcaftadine 0.25%, Olopatadine 0.2%, dextran 70 0.1%/hydroxypropyl methylcellulose 0.3% - Conjunctivitis, Allergic | Phase 4 | Completed | Allergan | 157 | 2012-11-01 | 2014-01-14 |
| A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis alcaftadine 0.25% ophthalmic solution, olopatadine 0.2% ophthalmic solution, dextran 70 0.1%/hydroxypropyl methylcellulose 0.3% - Conjunctivitis, Allergic | Phase 4 | Completed | Allergan | 127 | 2011-10-01 | 2013-02-21 |
| Comparison of Tolerability Between Two Allergy Drops alacaftadine and naphazoline HCl & pheniramine maleate - Allergic Conjunctivitis | Phase 4 | Unknown | Hom, Milton M., OD, FAAO | 48 | 2011-08-01 | 2011-07-11 |
| Safety and Efficacy Study of a Eye Drop for Eye Allergy alcaftadine, Placebo - Allergic Conjunctivitis | Phase 3 | Completed | Vistakon Pharmaceuticals | 60 | 2009-04-01 | 2015-03-06 |
Allergan (3) · Hom, Milton M., OD, FAAO (1) · ORA, Inc. (1) · Starx Research Center, LLC (1) · Vistakon Pharmaceuticals (1)
United States (5) · South Korea (1)
Jayesh Kanuga, MD (1) · Yan Bai (1)